Status:
COMPLETED
Topical Intra-Oral Ketoprofen for Migraine Prevention
Lead Sponsor:
Behar, Caren, M.D.
Conditions:
Migraine
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
Intra-Oral Topical Ketoprofen gel, applied to a branch of the trigeminal nerve, has been shown to prevent migraines when used once daily for 3 months in open label studies. This is a randomized, doubl...
Detailed Description
This is a 4 month trial. During the first month, a prospective headache diary is maintained. Migraine frequency, severity (1-10), duration, and all headache medications are recorded. Patients are the...
Eligibility Criteria
Inclusion
- IHS Migraine with or without aura
- 18 y.o. or older
- at least 4 migraines per month
Exclusion
- pregnancy
- other headache conditions
- chronic daily headache
- allergy or sensitivity to NSAIDs other severe illnesses
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2011
Estimated Enrollment :
67 Patients enrolled
Trial Details
Trial ID
NCT01211795
Start Date
October 1 2009
End Date
June 1 2011
Last Update
June 8 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York Medical College
Valhalla, New York, United States, 10595